Views & Analysis Steps to building a more patient-centric industry Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials.
Partner Content Partner Content Illuminating Real-Time Patient Needs Through Socially Driven... Data collected via social health adds context, recency
Views & Analysis A Reuters Pharma conversation with EY: smart reviewing and p... Harking back to the Reuters Pharma 2022 event, held at the Nice Acropolis convention centre on France’s South Coast back in October, pharmaphorum had a chance to drop by the booth of EY and
Views & Analysis Propelling clinical research into the 21st century Two and a half years ago, Covid-19 began to infect hundreds, then thousands, then millions of people, and was eventually declared a global pandemic.
Partner Content Partner Content 6 Ways to Prioritize the Patient Voice in Patient Journey Re... 6 ways to bring the patient voice to the forefront
Views & Analysis How one pharma “family business” places patients first When people think about pharma, they often think about “big” pharma: large, faceless corporations.
News PBM reform dropped in Congress' funding package Proposed reforms to the regulations for PBMs were dropped from the US Congress' end-of-year bill to provide funding to the federal government.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.